5′-amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter

被引:268
作者
Han, HK
de Vrueh, RLA
Rhie, JK
Covitz, KMY
Smith, PL
Lee, CP
Oh, DM
Sadee, W
Amidon, GL [1 ]
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands
[3] Univ Calif San Francisco, Dept Biopharmaceut Sci & Pharmaceut Chem, San Francisco, CA 94143 USA
[4] Smith Kline Beecham Pharmaceut, Dept Drug Delivery, Pharmaceut Technol, Collegeville, PA 19426 USA
关键词
amino acid ester; PEPT1; transporter; permeability; prodrugs;
D O I
10.1023/A:1011919319810
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. General use of nucleoside analogues in the treatment of viral infections and cancer is often limited by poor oral absorption. Valacyclovir, a water soluble amino acid ester prodrug of acyclovir has been reported to increase the oral bioavailability of acyclovir but its absorption mechanism is unknown. This study characterized the intestinal absorption mechanism of 5'-amino acid ester prodrugs of the antiviral drugs and examined the potential of amino acid esters as an effective strategy for improving oral drug absorption. Methods. Acyclovir(ACV) and Zidovudine (AZT) were selected as the different sugar-modified nucleoside antiviral agents and synthesized to L-valyl esters of ACV and AZT (L-Val-ACV and L-Val-AZT), D-valyl ester of ACV (D-Val-ACV) and glycyl ester of ACV (Gly-ACV). The intestinal absorption mechanism of these 5'-amino acid ester prodrugs was characterized in three different experimental systems; in situ rat perfusion model, CHO/hPEPT1 cells and Caco-2 cells. Results. Testing 5'-amino acid ester prodrugs of acyclovir and AZT, we found that the prodrugs increased the intestinal permeability of the parent nucleoside analogue 3- to IO-fold. The dose- dependent permeation enhancement was selective for the L-amino acid esters. Competitive inhibition studies in rats and in CHO cells transfected with the human peptide transporter, hPEPT1, demonstrated that membrane transport of the prodrugs was mediated predominantly by the PEPT1 H+/dipeptide cotransporter even though these prodrugs did not possess a peptide bond. Finally, transport studies in Caco-2 cells confirmed that the 5'-amino acid ester prodrugs enhanced the transcellular transport of the parent drug. Conclusions, This study demonstrates that L-amino acid-nucleoside chimeras can serve as prodrugs to enhance intestinal absorption via the PEPT1 transporter providing a novel strategy for improving oral therapy of nucleoside drugs.
引用
收藏
页码:1154 / 1159
页数:6
相关论文
共 27 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
BAI JPF, 1994, HANDB EXP PHARMACOL, V110, P189
[3]   AMINO-ACID ESTER PRODRUGS OF ACYCLOVIR [J].
BEAUCHAMP, LM ;
ORR, GF ;
DEMIRANDA, P ;
BURNETTE, T ;
KRENITSKY, TA .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (03) :157-164
[4]  
BUNDGAARD H, 1995, DESIGN PRODRUGS, P1
[5]   Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells [J].
Covitz, KMY ;
Amidon, GL ;
Sadee, W .
PHARMACEUTICAL RESEARCH, 1996, 13 (11) :1631-1634
[6]  
DELEAN A, 1978, J NEUROCHEM, V235, pE97
[7]   PHARMACOKINETICS OF ACYCLOVIR AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
DEMIRANDA, P ;
BLUM, MR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :29-37
[8]   PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF 2 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR PRODRUGS IN RATS - ENALAPRIL AND FOSINOPRIL [J].
FRIEDMAN, DI ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1989, 6 (12) :1043-1047
[9]   INVITRO MEASUREMENT OF GASTROINTESTINAL TISSUE PERMEABILITY USING A NEW DIFFUSION CELL [J].
GRASS, GM ;
SWEETANA, SA .
PHARMACEUTICAL RESEARCH, 1988, 5 (06) :372-376
[10]   RENIN INHIBITOR - RELATIONSHIP BETWEEN MOLECULAR-STRUCTURE AND ORAL ABSORPTION [J].
HASHIMOTO, N ;
FUJIOKA, T ;
HAYASHI, K ;
ODAGUCHI, K ;
TOYODA, T ;
NAKAMURA, M ;
HIRANO, K .
PHARMACEUTICAL RESEARCH, 1994, 11 (10) :1443-1447